Vertex Pharmaceuticals EPS Diluted (TTM) Analysis | YCharts

Vertex Pharmaceuticals, Inc. (VRTX)

547.29 -5.56 (-1.01%) USD | NASDAQ | Aug 26, 16:00

541.50 -5.79 (-1.06%) Pre-Market: 09:01

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted (TTM) Chart

Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	17.19
March 31, 2026	16.87
December 31, 2025	15.33
September 30, 2025	14.19
June 30, 2025	13.99
March 31, 2025	-3.922
December 31, 2024	-2.202
September 30, 2024	-1.993
June 30, 2024	-2.026
March 31, 2024	15.41
December 31, 2023	13.89
September 30, 2023	13.32
June 30, 2023	12.94
March 31, 2023	12.55
December 31, 2022	12.82
September 30, 2022	12.67
June 30, 2022	12.36
March 31, 2022	9.488
December 31, 2021	9.027
September 30, 2021	8.327
June 30, 2021	7.574
March 31, 2021	10.50
December 31, 2020	10.29
September 30, 2020	10.22
June 30, 2020	7.912

Date	Value
March 31, 2020	5.763
December 31, 2019	4.505
September 30, 2019	8.250
June 30, 2019	8.529
March 31, 2019	8.30
December 31, 2018	8.08
September 30, 2018	2.50
June 30, 2018	1.59
March 31, 2018	0.86
December 31, 2017	1.04
September 30, 2017	0.78
June 30, 2017	1.03
March 31, 2017	0.70
December 31, 2016	-0.46
September 30, 2016	-0.90
June 30, 2016	-1.13
March 31, 2016	-1.65
December 31, 2015	-2.31
September 30, 2015	-2.74
June 30, 2015	-3.07
March 31, 2015	-2.97
December 31, 2014	-3.14
September 30, 2014	-2.21
June 30, 2014	-2.03
March 31, 2014	-1.61

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks

Start Trial

Gilead Sciences, Inc.	-2.656
Alnylam Pharmaceuticals, Inc.	5.923
Regeneron Pharmaceuticals, Inc.	40.46
Sionna Therapeutics, Inc.	-2.169
Biogen, Inc.	5.647